6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Latest Press Releases

Time	Headline
12m ago	Garrett Motion Reports First Quarter 2026 Financial Results, Raises 2026 Outlook
12m ago	ADT Reports First Quarter 2026 Results
12m ago	Labcorp Announces 2026 First Quarter Results; Raises Full Year 2026 Guidance
12m ago	Kimco Realty® Announces First Quarter 2026 Results
13m ago	Granite Reports First Quarter 2026 Results

About

Context Therapeutics Inc (NASDAQ:CNTX) — investor relations, events, news, and company updates on 6ix.

Latest News

Context Therapeutics Announces CTIM-76 Receives FDA Fast Track Designation for the Treatment of Platinum-Resistant Ovarian Cancer

Context Therapeutics Reports Full Year 2025 Operating and Financial Results

Context Therapeutics Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2026

Context Therapeutics to Participate in Upcoming Investor Conferences

Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Financials

Revenue

$0

Market Cap

$249.91 M

EPS

-0.38

Community Chat

Ask AI